100 related articles for article (PubMed ID: 16120173)
1. Ingestion of topical steroid triggering pustular psoriasis?
Orpin SD; Hafiji J; Goodyear HM; Salim A
Br J Dermatol; 2005 Sep; 153(3):680-2. PubMed ID: 16120173
[No Abstract] [Full Text] [Related]
2. Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid.
Saeki H; Watanabe A; Tada Y; Kakinuma T; Komine M; Ihn H; Asahina A; Etoh T; Kitanaka S; Sato U; Kano H; Igarashi T; Tamaki K
J Dermatol; 2008 Sep; 35(9):601-3. PubMed ID: 18837708
[No Abstract] [Full Text] [Related]
3. Cushing's syndrome caused by topical steroid therapy for psoriasis.
Abma EM; Blanken R; De Heide LJ
Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
[TBL] [Abstract][Full Text] [Related]
4. An infantile Cushing syndrome due to misuse of topical steroid.
Siklar Z; Bostanci I; Atli O; Dallar Y
Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
[TBL] [Abstract][Full Text] [Related]
5. Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent.
Tobin AM; Barragry J; Kirby B; O'Shea L
Ir Med J; 2005 Apr; 98(4):118. PubMed ID: 15938560
[No Abstract] [Full Text] [Related]
6. Porokeratosis of Mibelli induced by topical corticosteroid.
Yazkan F; Turk BG; Dereli T; Kazandi AC
J Cutan Pathol; 2006 Jul; 33(7):516-8. PubMed ID: 16872477
[TBL] [Abstract][Full Text] [Related]
7. Penetration of topical steroid preparations.
Carruthers JA; Staughton RC; August PJ
Arch Dermatol; 1977 Apr; 113(4):522. PubMed ID: 848992
[No Abstract] [Full Text] [Related]
8. Sequelae from inadvertent long-term use of potent topical steroids.
Beer K; Downie J
J Drugs Dermatol; 2007 May; 6(5):550-1. PubMed ID: 17679193
[TBL] [Abstract][Full Text] [Related]
9. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area.
Semiz S; Balci YI; Ergin S; Candemir M; Polat A
Pediatr Dermatol; 2008; 25(5):544-7. PubMed ID: 18950396
[TBL] [Abstract][Full Text] [Related]
10. Keeping psoriasis under wraps.
Griffiths CE
J Dermatolog Treat; 2001 Sep; 12(3):133. PubMed ID: 12243702
[No Abstract] [Full Text] [Related]
11. Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment.
Brenner M; Molin S; Ruebsam K; Weisenseel P; Ruzicka T; Prinz JC
Br J Dermatol; 2009 Oct; 161(4):964-6. PubMed ID: 19681858
[No Abstract] [Full Text] [Related]
12. Cushing syndrome from topical foam steroid use in an adolescent male.
Gold-von Simson G; Kohn B; Axelrod FB
Clin Pediatr (Phila); 2006; 45(1):97-100. PubMed ID: 16429224
[No Abstract] [Full Text] [Related]
13. Trichostasis spinulosa: possible association with prolonged topical application of clobetasol propionate 0.05% cream.
Janjua SA; McKoy KC; Iftikhar N
Int J Dermatol; 2007 Sep; 46(9):982-5. PubMed ID: 17822507
[No Abstract] [Full Text] [Related]
14. Clobetasol propionate (Clobex) spray for psoriasis.
Med Lett Drugs Ther; 2006 Mar; 48(1231):27-8. PubMed ID: 16554700
[No Abstract] [Full Text] [Related]
15. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
Lee CS; Koo J
J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
[TBL] [Abstract][Full Text] [Related]
16. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
17. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial.
Conrotto D; Carbone M; Carrozzo M; Arduino P; Broccoletti R; Pentenero M; Gandolfo S
Br J Dermatol; 2006 Jan; 154(1):139-45. PubMed ID: 16403107
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients.
Sánchez Regaña M; Martín Ezquerra G; Umbert Millet P; Llambí Mateos F
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):573-7. PubMed ID: 16164711
[TBL] [Abstract][Full Text] [Related]
19. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
Andres P; Poncet M; Farzaneh S; Soto P
J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
[TBL] [Abstract][Full Text] [Related]
20. 'Coral reef' psoriasis: a marker of resistance to topical treatment.
Feldman SR; Brown KL; Heald P
J Dermatolog Treat; 2008; 19(5):257-8. PubMed ID: 18608734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
